Irenic Capital Management LP Purchases Shares of 332,042 Ralliant Corporation $RAL

Irenic Capital Management LP acquired a new stake in Ralliant Corporation (NYSE:RAL) in the 4th quarter, Holdings Channel reports. The fund acquired 332,042 shares of the company’s stock, valued at approximately $16,904,000. Ralliant accounts for about 1.1% of Irenic Capital Management LP’s portfolio, making the stock its 15th largest holding.

Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. Allworth Financial LP raised its position in shares of Ralliant by 134.4% in the 4th quarter. Allworth Financial LP now owns 511 shares of the company’s stock valued at $26,000 after purchasing an additional 293 shares during the last quarter. Rothschild Investment LLC raised its position in shares of Ralliant by 98.1% in the 4th quarter. Rothschild Investment LLC now owns 612 shares of the company’s stock valued at $31,000 after purchasing an additional 303 shares during the last quarter. Keybank National Association OH raised its position in shares of Ralliant by 1.6% in the 4th quarter. Keybank National Association OH now owns 19,667 shares of the company’s stock valued at $1,001,000 after purchasing an additional 305 shares during the last quarter. UMB Bank n.a. raised its position in shares of Ralliant by 49.6% in the 4th quarter. UMB Bank n.a. now owns 983 shares of the company’s stock valued at $50,000 after purchasing an additional 326 shares during the last quarter. Finally, Maryland State Retirement & Pension System raised its position in shares of Ralliant by 1.5% in the 4th quarter. Maryland State Retirement & Pension System now owns 21,940 shares of the company’s stock valued at $1,117,000 after purchasing an additional 329 shares during the last quarter.

Ralliant Price Performance

Shares of NYSE:RAL opened at $67.50 on Thursday. Ralliant Corporation has a twelve month low of $37.27 and a twelve month high of $70.22. The company’s 50 day moving average is $54.62 and its 200 day moving average is $50.26. The company has a current ratio of 1.61, a quick ratio of 1.05 and a debt-to-equity ratio of 0.73. The company has a market cap of $7.56 billion and a PE ratio of -6.17.

Ralliant (NYSE:RAL) last issued its quarterly earnings results on Tuesday, May 12th. The company reported $0.57 earnings per share for the quarter, topping the consensus estimate of $0.49 by $0.08. Ralliant had a negative net margin of 58.55% and a positive return on equity of 12.49%. The company had revenue of $534.60 million for the quarter. The company’s revenue was up 11.0% on a year-over-year basis. Ralliant has set its FY 2026 guidance at 2.530-2.690 EPS and its Q2 2026 guidance at 0.580-0.640 EPS. On average, sell-side analysts forecast that Ralliant Corporation will post 2.64 EPS for the current year.

Ralliant Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 23rd. Investors of record on Monday, June 8th will be issued a $0.05 dividend. This represents a $0.20 annualized dividend and a yield of 0.3%. The ex-dividend date is Monday, June 8th. Ralliant’s dividend payout ratio is -1.83%.

Wall Street Analyst Weigh In

Several equities analysts recently commented on the stock. Vertical Research lowered shares of Ralliant from a “buy” rating to a “hold” rating and set a $65.00 price objective for the company. in a research report on Wednesday, May 27th. Zacks Research raised shares of Ralliant from a “strong sell” rating to a “hold” rating in a research report on Monday, April 13th. TD Cowen increased their price objective on shares of Ralliant from $55.00 to $70.00 and gave the company a “buy” rating in a research report on Wednesday, May 20th. Morgan Stanley increased their price objective on shares of Ralliant from $45.00 to $68.00 and gave the company an “overweight” rating in a research report on Thursday, May 14th. Finally, Weiss Ratings reaffirmed a “sell (d)” rating on shares of Ralliant in a research report on Monday, May 4th. Seven analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $67.30.

Ralliant Company Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.